Population
Single myocytes dissociated from guinea-pig ventricles
Design
Preclinical
Authors
Loading...
May guide I(Ks)-targeted drug design; leaves open clinical utility in humans.
Chromanol 293B acts as an open channel blocker of the slowly activating delayed rectifier K+ current (I(Ks)) with a 1:1 binding stoichiometry.
Fujisawa et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: